Duke University

Use of potentially inappropriate medications, as defined by the American Geriatrics Society Beers Criteria, was linked to an increased risk for hospitalizations, falls and mortality in adults with chronic kidney disease.

Once weekly selinexor, carfilzomib and dexamethasone was highly active and yielded deep responses in patients with heavily pretreated multiple myeloma, according to data presented at the virtual ASCO Annual Meeting.

Allogeneic hematopoietic cell transplantation showed potential in patients with high-risk multiple myeloma, according to findings presented at the ASCO Annual Meeting.

Cristina Gasparetto, MD, director of the multiple myeloma program at Duke University, discussed data on bispecific T-cell engagers currently being studied in relapsed and refractory multiple myeloma presented at the virtual ASCO Annual Meeting

The last few years have yielded “incredible numbers of new drugs approved and under development” in multiple myeloma, Cristina Gasparetto, MD, director of the multiple myeloma program at Duke University, told Healio in a video interview.

Once weekly oral selinexor combined with pomalidomide and dexamethasone was well-tolerated in patients with heavily pretreated multiple myeloma, according to data from the multi-arm phase 1b/2 STOMP study presented at the virtual ASCO Annual Meeting.

Aspirin 81 mg daily vs. 325 mg daily for secondary CVD prevention.

Patients with peripheral artery disease and HF have higher rates of CAD and elevated risk for adverse CV events and mortality compared with patients with PAD but no HF, researchers reported.

Transitioning from pediatric to adult diabetes care is associated with a prolonged gap in care for teens and young adults who do not see a diabetes educator or use a continuous glucose monitor, according to a speaker.

While the majority of surgeons in the United States routinely resurface patellae during every TKA, the data and modern understanding of TKA fail to support this practice.